SYNGENE INTERNATIONAL Share price

The Company was incorporated as Syngene International Private Limited on November 18 1993 at Bengaluru Karnataka as a private limited company under the Companies Act 1956. Pursuant to a special resolution of the shareholders dated March 26 2007 the Company was converted into a public limited company and the name of the Company was changed to Syngene International Limited. A fresh certificate of incorporation consequent upon conversion to public limited company was issued on April 19 2007. the Company was promoted by Kiran Mazumdar Shaw a promoter of Biocon. On March 30 2002 99.9 percent of the Equity Shares of the Company were transferred to Biocon and as a result the Company became the subsidiary of Biocon. Biocon has since been the Promoter of the Company.The details of changes in the registered office of the Company are given below: From 20th KM Hosur Road Electronics City P.O Bengaluru 560 100 Karnataka India to Biocon Special Economic Zone Biocon Park Plot No. 2 and 3 Bommasandra Industrial Area IV Phase Jigani Link Road Bommasandra Bengaluru 560 099 Karnataka India.Major events and milestones of the Company :1994 -Initiated operations as a CRO with services in chemistry and biology1998 -Granted 100% Export Oriented Unit (EOU) status by the Government of India 1999 -First operational expansion in R&D by way of expansion of lab space to over 23000 sq. ft. 2000 -CIL was incorporated as a 100% subsidiary of Biocon to provide clinical research services to domestic and multinational companies 2001 -Forayed into chemical development with a dedicated manufacturing facility 2003 -Moved to Biocon Park a 90 acre biopharmaceutical SEZ with operations spread over 65000 sq. ft. 2007-Bristol-Myers Squibb and the Company signed the first long term contract to set up the first dedicated R&D centre -Expansion of research facilities at Biocon SEZ to 148000 sq. ft. -Crossed an annual turnover of over `1000 million in Financial Year 2007 2009-Dupont Crop Protection and the Company extended a partnership for R&D services -Expansion of manufacturing services with a new plant which is cGMP compliant -Initiated operations in safety assessment and large molecules development services 2010-Acceptance of the clinical and bio-analytical facilities of CIL by the Department of Health & Human Services FDA -Initiated operations in formulation development 2011-Endo Pharmaceuticals and the Company collaborated to develop novel biological therapeutic molecules against cancer 2012-Abbott and the Company collaborated to establish Abbott's nutrition research and development centre in India and the second R&D centre -Certification of the clinical facilities by ANVISA -Acquired 100% stake in Clinigene International Limited from Biocon 2013 -Crossed an annual turnover of over `5000 million in Financial Year 2013 -Baxter International Inc. collaborated with the Company to establish the ?Baxter Global Research Center? the third dedicated R&D centre -Acceptance of the control testing laboratory by the Department of Health & Human Services FDA 2014-Bristol-Myers Squibb and the Company extend collaboration for its dedicated R&D centre till 2020 -Acceptance of the API manufacturing facility by the Department of Health & Human Services FDA -Established a 75000 sq.ft centre to provide stability and analytical services 2015-CIL was amalgamated with the Company Awards Recognitions and Accreditations :2009- Bangalore Bio Bio Excellence Award ? Biotech Services Sector - Best BioServices company of the year by Biospectrum 2012- ISO 9001:2008 for contract research in drug discovery and contract manufacturing of biopharmaceuticals - AAALAC accreditation for conforming to the ?Guide for the Care and Use of Laboratory Animals and the Committee for the Purpose of Control and Supervision of Experiments on Animals guidelines? 2013- Bioservices - ABLE Tenth Anniversary Award ? Outstanding contribution to Bioservices - Diamond sponsor recognition by the Association of Scientists of Indian Origin of the Society of Toxicology 2014- ISO 14001:2004 for contract research in drug discovery and contract manufacturing of biopharmaceuticals - BS OHSAS 18001:2007 for contract research in drug discovery and contract manufacturing of biopharmaceuticals - Silver EDGE Award - EHS best practices award by CII - SAP Ace Award for special recognition for complex SAP implementation - Level I Laboratory certification issued by the NGSP to Clinigene International Limited 2015- Accreditation by the College of American Pathologists in relation to their laboratory accreditation program - Bangalore India Bio ? Bio Excellence Award for outstanding contribution to the Biotech services sector - ISO 15189:2007 in the field of medical testing